Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Publication Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) CertaraNovember 15, 2016
IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success Brochure IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success In vitro-in vivo correlation (IVIVC) is an important, predictive mathematical tool in drug development, used…CertaraNovember 8, 2016
Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan Press Release Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan PRINCETON, NJ – Oct. 13, 2016 – Certara, the leading provider of decision support technology…CertaraOctober 13, 2016
Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models Publication Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models CertaraOctober 5, 2016
A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion Publication A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion Metritis is a frequent problem in postpartum dairy cows. Intrauterine therapy with the antimicrobial oxytetracycline…CertaraOctober 1, 2016
Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains Publication Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains CertaraOctober 1, 2016
Arming Adherence-based Drug Development with Pharmacometrics Blog Arming Adherence-based Drug Development with Pharmacometrics The time is right to explore how sensor-enabled digital adherence monitoring systems can benefit patients,…CertaraSeptember 12, 2016
Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists Brochure Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists Phoenix NLME is the PK/PD modeling software that is user-friendly and easy-to-learn. Built from the…CertaraSeptember 12, 2016
Rare Disease and Orphan Drug Development Brochure Rare Disease and Orphan Drug Development There are 7,000 rare diseases impacting 350 million patients worldwide, yet only 300 of these…CertaraAugust 3, 2016
Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation Publication Population Pharmacokinetics of Bevacizumab in Cancer Patients with External Validation CertaraAugust 1, 2016